460 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
U.S. Stocks Close Little Changed Ahead Of Inflation Data https://www.rttnews.com/story.aspx?Id=3435701 Mar 28, 2024 - Following the strong upward move seen late in Wednesday's session, stocks showed a lack of direction over the course of the trading day on Thursday. Despite the choppy trading, the Dow and the S&P 500 reached new record closing highs. The major averages eventually ended the session narrowly mixed.
U.S. Stocks Lack Direction As Inflation Data Looms https://www.rttnews.com/story.aspx?Id=3435647 Mar 28, 2024 - Following the strong upward move seen late in the previous session, stocks are showing a lack of direction during trading on Thursday. The major averages have spent the day bouncing back and forth across the unchanged line. Currently, the major averages are slightly higher.
Are the restaurant menu items for April Fool's Day still outrageous? https://www.nrn.com/first-bite/are-restaurant-menu-items-april-fools-day-still-outrageous Mar 28, 2024 - Ahead of April Fool’s Day, chains have been releasing menu items that may be real. This is a tradition in the restaurant industry where brands promote various menu items that seem outlandish in the hopes that they will drive customers to their stores
Top Analyst Reports for Meta Platforms, S&P Global & AT&T https://www.zacks.com/commentary/2246613/top-analyst-reports-for-meta-platforms-s-p-global-at-t?cid=CS-ZC-FT-research_daily-2246613 Mar 27, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), S&P Global Inc. (SPGI) and AT&T Inc. (T).
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests https://www.cnbc.com/2024/03/27/novo-nordisk-ozempic-can-be-made-for-less-than-5-a-month-study.html Mar 27, 2024 - Researchers found Novo Nordisk's Ozempic could be manufactured for an estimated 89 cents to $4.73 for a month's supply, figures that include a profit margin.
Dow, S&P 500 Poised To Snap Three-Day Losing Streaks https://www.rttnews.com/story.aspx?Id=3435312 Mar 27, 2024 - Stocks gave back ground after an early move to the upside but remain mostly positive in afternoon trading on Wednesday. With the gains, the Dow and the S&P 500 are poised to snap their three-day losing streaks.
Viking Therapeutics stock jumps more than 15% on promising weight loss pill data https://www.cnbc.com/2024/03/26/viking-therapeutics-weight-loss-pill-shows-positive-study-results.html Mar 26, 2024 - The Viking study results add to the growing excitement around the biotech company and its potential in the budding weight loss market.
S&P 500's Bull Run to Continue: ETFs to Bet On https://www.zacks.com/stock/news/2246075/s-p-500-s-bull-run-to-continue-etfs-to-bet-on?cid=CS-ZC-FT-etf_news_and_commentary-2246075 Mar 26, 2024 - Wall Street analysts have become more bullish on the S&P 500. In order to tap this opportune moment, investors should bet on ETFs that track the S&P 500 Index.
U.S. Stocks Seeing Modest Weakness Amid Cautious Trading https://www.rttnews.com/story.aspx?Id=3434582 Mar 25, 2024 - Following the lackluster performance seen during last Friday's session, stocks are seeing modest weakness during trading on Monday. The major averages have all moved to the downside after ending the previous session mixed. Currently, the major averages are off their lows of the session but still in the red.
Kaiser Aluminum (KALU)'s Technical Outlook is Bright After Key Golden Cross https://www.zacks.com/stock/news/2245519/kaiser-aluminum-kalu-s-technical-outlook-is-bright-after-key-golden-cross?cid=CS-ZC-FT-tale_of_the_tape|golden_crossover-2245519 Mar 25, 2024 - Is it a good or bad thing when a stock experiences a golden cross technical event?

Pages: 1...7891011121314151617...46

<<<Page 12>